Index of reports
> Cases with Abnormal Behaviour (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Droperidol where reactions include abnormal behaviour. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Droperidol side effects in 26 year old male
Reported by a physician from Australia on 2012-07-16
Patient: 26 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Blood Bilirubin Increased, Schizoaffective Disorder, Cholestasis, Abnormal Behaviour, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2012-03-14
Olanzapine
Indication: Schizoaffective Disorder
Clopixol Acuphase
Indication: Schizoaffective Disorder
Droperidol
Indication: Schizoaffective Disorder
Alcohol
Indication: Product Used FOR Unknown Indication
Risperidone
Administration route: Oral
Indication: Schizoaffective Disorder
Risperidone
Administration route: Oral
Possible Droperidol side effects in 26 year old male
Reported by a physician from Australia on 2012-06-15
Patient: 26 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Blood Bilirubin Increased, Hospitalisation, Cholestasis, Abnormal Behaviour, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Droperidol
Indication: Schizoaffective Disorder
Clopixol Acuphase
Indication: Schizoaffective Disorder
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2012-03-14
Risperidone
Administration route: Oral
Indication: Schizoaffective Disorder
Alcohol
Indication: Product Used FOR Unknown Indication
Olanzapine
Indication: Schizoaffective Disorder
Risperidone
Administration route: Oral
Possible Droperidol side effects in 26 year old male
Reported by a physician from Australia on 2012-04-02
Patient: 26 year old male
Reactions: Blood Bilirubin Increased, Hospitalisation, Abnormal Behaviour, Cholestasis, Hepatic Enzyme Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizoaffective Disorder
Risperidone
Administration route: Oral
Indication: Schizoaffective Disorder
Clopixol Acuphase
Indication: Schizoaffective Disorder
Risperidone
Administration route: Oral
Droperidol
Indication: Schizoaffective Disorder
Olanzapine
Indication: Schizoaffective Disorder
Alcohol
Indication: Product Used FOR Unknown Indication
|